Procter & Gamble (NYSE:PG) had its price target lifted by investment analysts at Morgan Stanley from $90.00 to $92.00 in a research note issued to investors on Thursday. The brokerage currently has an “equal weight” rating on the stock. Morgan Stanley’s price target points to a potential upside of 4.18% from the company’s current price.
A number of other equities analysts have also issued reports on PG. Zacks Investment Research upgraded shares of Procter & Gamble from a “hold” rating to a “buy” rating and set a $102.00 target price for the company in a research report on Monday, January 8th. Stifel Nicolaus set a $87.00 target price on shares of Procter & Gamble and gave the company a “hold” rating in a research report on Friday, October 20th. Goldman Sachs Group upgraded shares of Procter & Gamble from a “sell” rating to a “neutral” rating and set a $77.00 target price for the company in a research report on Tuesday, January 16th. Jefferies Group reiterated a “buy” rating and issued a $104.00 target price on shares of Procter & Gamble in a research report on Tuesday, October 10th. Finally, Vetr upgraded shares of Procter & Gamble from a “hold” rating to a “buy” rating and set a $93.02 target price for the company in a research report on Monday, October 23rd. One research analyst has rated the stock with a sell rating, ten have given a hold rating and nine have given a buy rating to the company’s stock. Procter & Gamble currently has a consensus rating of “Hold” and a consensus target price of $88.01.
Procter & Gamble (NYSE PG) traded down $0.74 during mid-day trading on Thursday, hitting $88.31. 15,139,399 shares of the company were exchanged, compared to its average volume of 8,422,400. The company has a debt-to-equity ratio of 0.41, a quick ratio of 0.75 and a current ratio of 0.94. Procter & Gamble has a 1-year low of $85.42 and a 1-year high of $94.67. The firm has a market cap of $224,340.00, a PE ratio of 23.55, a PEG ratio of 2.85 and a beta of 0.67.
In other news, insider R. Alexandra Keith sold 1,298 shares of the stock in a transaction that occurred on Wednesday, November 29th. The shares were sold at an average price of $89.11, for a total value of $115,664.78. Following the completion of the sale, the insider now directly owns 20,135 shares of the company’s stock, valued at $1,794,229.85. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Carolyn M. Tastad sold 5,300 shares of the stock in a transaction that occurred on Monday, November 13th. The stock was sold at an average price of $89.18, for a total transaction of $472,654.00. Following the completion of the sale, the insider now directly owns 57,191 shares of the company’s stock, valued at $5,100,293.38. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 18,719 shares of company stock valued at $1,661,544. Insiders own 0.35% of the company’s stock.
Several hedge funds and other institutional investors have recently bought and sold shares of PG. Asset Planning Services Ltd. raised its position in shares of Procter & Gamble by 0.4% in the second quarter. Asset Planning Services Ltd. now owns 1,191 shares of the company’s stock valued at $104,000 after purchasing an additional 5 shares during the period. Harding Loevner LP bought a new position in shares of Procter & Gamble in the second quarter valued at approximately $119,000. Cerebellum GP LLC bought a new position in shares of Procter & Gamble in the fourth quarter valued at approximately $122,000. Kohmann Bosshard Financial Services LLC bought a new position in shares of Procter & Gamble in the third quarter valued at approximately $125,000. Finally, Blume Capital Management Inc. raised its position in shares of Procter & Gamble by 25.4% in the second quarter. Blume Capital Management Inc. now owns 1,482 shares of the company’s stock valued at $129,000 after purchasing an additional 300 shares during the period. 59.57% of the stock is owned by institutional investors and hedge funds.
About Procter & Gamble
The Procter & Gamble Company is focused on providing branded consumer packaged goods to the consumers across the world. The Company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care, and Baby, Feminine & Family Care. The Company sells its products in approximately 180 countries and territories primarily through mass merchandisers, grocery stores, membership club stores, drug stores, department stores, distributors, baby stores, specialty beauty stores, e-commerce, high-frequency stores and pharmacies.
